Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Coupang Is a Strong Buy on the Dip Despite Reported Losses

By Chris Lau, InvestorPlace Contributor

Markets sold CPNG stock because of inventory losses related to a fire -- a one-time event that will not slow its long-term growth.

Why Alibaba Stock Is Not Yet Worth Buying

By Chris Lau, InvestorPlace Contributor

BABA stock has been falling after Beijing scrutinized its monopoly position and accepted its contribution to “Common Prosperity.”

Buy Roku as Its Streaming Hours Gear up to Rise Again

By Chris Lau, InvestorPlace Contributor

The ROKU stock selloff is unjustified. Its hours watched declined, but that's a temporary setback, especially with Roku's strong revenue growth.

7 Sagging Software Stocks That Are Ready to Rebound

By Chris Lau, InvestorPlace Contributor

These software stocks could rip higher as investors seek deals from out-of-favor firms in an already expensive market at all-time highs.

Developed World Boosters Offer Big Market for Eventual Novavax Vaccine

By Chris Lau, InvestorPlace Contributor

Novavax’s combination vaccine and its Covid-19 vaccine sales for Q1/2022 in Japan are positive drivers for its revenue in the years ahead.

Why Scarce Automobile Supply Will Not Lift Lucid Group Stock

By Chris Lau, InvestorPlace Contributor

Lucid has yet to sell a vehicle, leaving speculators to bet on the stock price relative to Tesla, a trade that will prove too risky.

Palantir Stock Could Be Ready to Rally Significantly From These Levels

By Chris Lau, InvestorPlace Contributor

Palantir a fan favorite for technology investors who bet the Foundry platform will lead to customer contracts worth over $100 million.

DiDi Global Stock Is a Great Buy Here If You Can Handle the Regulation Risk

By Chris Lau, InvestorPlace Contributor

DIDI is a gamble worth considering after sellers sold the stock on the way down, creating a bottom in the stock recently.

Cassava Stock Is a Bold Play That Could Pay Off Soon

By Chris Lau, InvestorPlace Contributor

Bears are attacking Cassava as it questions the quality of its clinical data and try to stop its study for treating Alzheimer’s disease.

7 Small-Cap Stocks That Are Diamonds in the Rough

By Chris Lau, InvestorPlace Contributor

Small-cap stocks have more upside when investors ignore them, leaving a wide mispricing and a discount big enough for investors. Here are the seven most under-followed companies with the biggest potential upside ahead.

Load More